tiprankstipranks
Advertisement
Advertisement

ENSC Stock Latest News

ENSC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Pre-EarningsENSC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2d ago
ENSC
Ensysce Acquires Cy Biopharma, Expands Pain Therapy Portfolio
PremiumCompany Announcements
Ensysce Acquires Cy Biopharma, Expands Pain Therapy Portfolio
13d ago
8K
ENSC
Ensysce Biosciences completes acquisition of Cy Biopharma
PremiumThe Fly
Ensysce Biosciences completes acquisition of Cy Biopharma
13d ago
ENSC
Ensysce Biosciences awarded $5.3M installment in NIDA funding
PremiumThe Fly
Ensysce Biosciences awarded $5.3M installment in NIDA funding
1M ago
ENSC
Ensysce Biosciences enrolls first patient in final stage of PF614-MPAR-102
PremiumThe Fly
Ensysce Biosciences enrolls first patient in final stage of PF614-MPAR-102
2M ago
ENSC
Ensysce Biosciences files to sell 1.3M shares of common stock for holders
PremiumThe FlyEnsysce Biosciences files to sell 1.3M shares of common stock for holders
3M ago
ENSC
Ensysce announces expansion of patent protection for MPAR technology
Premium
The Fly
Ensysce announces expansion of patent protection for MPAR technology
3M ago
ENSC
Ensysce secures IRB approval of final phase of PF614-MPAR-102 study
Premium
The Fly
Ensysce secures IRB approval of final phase of PF614-MPAR-102 study
4M ago
ENSC
Ensysce Biosciences files to sell 20.34M shares of common stock for holders
PremiumThe Fly
Ensysce Biosciences files to sell 20.34M shares of common stock for holders
4M ago
ENSC
Ensysce Biosciences Secures $2 Million Private Financing
PremiumCompany Announcements
Ensysce Biosciences Secures $2 Million Private Financing
4M ago
8K
ENSC
Ensysce Biosciences secures second financing from 2025 agreement
PremiumThe Fly
Ensysce Biosciences secures second financing from 2025 agreement
4M ago
ENSC
Ensysce Biosciences Announces Board Member Curtis Rosebraugh Resignation
PremiumCompany Announcements
Ensysce Biosciences Announces Board Member Curtis Rosebraugh Resignation
5M ago
8K
ENSC
ENSC Earnings this Week: How Will it Perform?
PremiumPre-EarningsENSC Earnings this Week: How Will it Perform?
5M ago
ENSC
Ensysce Biosciences Corrects Series B Preferred Stock Designation
Premium
Company Announcements
Ensysce Biosciences Corrects Series B Preferred Stock Designation
5M ago
8K
ENSC
Ensysce Biosciences announces initiation of ‘Ask Me Anything’ series
Premium
The Fly
Ensysce Biosciences announces initiation of ‘Ask Me Anything’ series
6M ago
ENSC
Ensysce Biosciences announces publication on MPAR technology
PremiumThe Fly
Ensysce Biosciences announces publication on MPAR technology
6M ago
ENSC
Ensysce Biosciences initiates review of strategic alternatives
PremiumThe Fly
Ensysce Biosciences initiates review of strategic alternatives
6M ago
ENSC
Ensysce Biosciences enrolls 50% of subjects in Phase 3 trial of PF614
PremiumThe Fly
Ensysce Biosciences enrolls 50% of subjects in Phase 3 trial of PF614
7M ago
ENSC
Ensysce Biosciences expands global opioid patent portfolio
PremiumThe Fly
Ensysce Biosciences expands global opioid patent portfolio
7M ago
ENSC
Ensysce Biosciences Shareholders Approve Key Corporate Actions
PremiumCompany AnnouncementsEnsysce Biosciences Shareholders Approve Key Corporate Actions
7M ago
8K
ENSC
Ensysce Biosciences receives EU patent for ADHD therapy
Premium
The Fly
Ensysce Biosciences receives EU patent for ADHD therapy
7M ago
ENSC
Ensysce’s PF614 Steps Forward in Phase 3 Post-Surgery Pain Trial: What Investors Should Watch
Premium
Company Announcements
Ensysce’s PF614 Steps Forward in Phase 3 Post-Surgery Pain Trial: What Investors Should Watch
7M ago
ENSC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >